Company Profiles

driven by the PitchBook Platform

Acesion Pharma

Description

Developer of medical drugs designed for the treatment of atrial fibrillation. The company's medical drugs develop treatments for atrial fibrillation which is the most common type of cardiac arrhythmia by following the concept of inhibiting a type of ion channel in heart cells that is involved in generating the electrical signals that regulate the heart's rhythm, providing consumers with chronic treatment to prevent the recurrence of AF and maintain normal heart rhythm.

2011

Founded

PRIVATE

Status

1-10

Employees

Early Stage VC

Latest Deal Type

$2.52M

Latest Deal Amount

$3.82M

Total Amount Raised

Description

Developer of medical drugs designed for the treatment of atrial fibrillation. The company's medical drugs develop treatments for atrial fibrillation which is the most common type of cardiac arrhythmia by following the concept of inhibiting a type of ion channel in heart cells that is involved in generating the electrical signals that regulate the heart's rhythm, providing consumers with chronic treatment to prevent the recurrence of AF and maintain normal heart rhythm.

Website:

www.acesionpharma.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Pharmaceuticals
Drug Discovery

Primary Office

Ole Maaløes Vej 3 2200 Copenhagen NDenmark +45 2044 2073
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Acesion Pharma's full profile, request a free trial.

    Acesion Pharma Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Acesion Pharma Investors (5)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Broadview VenturesVenture CapitalMinority000 0000000 0000
    Innovation Fund DenmarkOther000 0000000 0000
    NovoCorporate Venture CapitalMinority000 0000000 0000
    SEED Capital DenmarkVenture CapitalMinority000 0000000 0000
    Wellcome TrustLimited Partner000 0000000 0000
    Broadview Ventures Venture Capital
    Innovation Fund Denmark Other
    Novo Corporate Venture Capital
    SEED Capital Denmark Venture Capital
    Wellcome Trust Limited Partner

    Acesion Pharma Executive Team (7)

    NameTitleBoard
    Seat
    Contact
    Info
    Frans Wuite MDChief Executive Officer
    Jakob Dynnes HansenChief Financial Officer
    Ulrik Sørensen Ph.DChief Operating Officer & Co-Founder
    Morten Grunnet Ph.DCo-Founder & Chief Scientific Officer & Board Member
    Christina SylvestSenior Vice President, Acute Cardioversion
    Frans Wuite MD Chief Executive Officer
    Jakob Dynnes Hansen Chief Financial Officer
    Ulrik Sørensen Ph.D Chief Operating Officer & Co-Founder
    Morten Grunnet Ph.D Co-Founder & Chief Scientific Officer & Board Member
    Christina Sylvest Senior Vice President, Acute Cardioversion

    Acesion Pharma Board Members (6)

    NameRepresentingRoleSinceContact
    Info
    Carsten Schou Ph.DSEED Capital DenmarkGeneral Partner000 0000
    Christopher De Souza Ph.DBroadview VenturesDirector000 0000
    Ingelise SaundersSelfChairman000 0000
    Lars Gredsted Ph.DAcesion PharmaBoard Member000 0000
    Paul Goldenheim MDSelfBoard Member000 0000
    Carsten Schou Ph.D General Partner SEED Capital Denmark
    Christopher De Souza Ph.D Director Broadview Ventures
    Ingelise Saunders Chairman Self
    Lars Gredsted Ph.D Board Member Acesion Pharma
    Paul Goldenheim MD Board Member Self
    Request full access to PitchBook